Estrogen Receptor Positive Breast Cancer Completed Phase 1 Trials for Fulvestrant (DB00947)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01219699A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA GeneTreatment
NCT01339442BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast CancerTreatment